XTLB Competitors & Alternatives
Compare XTL Biopharmaceuticals Ltd ADR with similar stocks in the same industry
Biotechnology
XTLB
Main Stock$1.60
Tradestie Score
58
Market Cap
$10.14M
Analyst Upside
+1775.0%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.24
|
$154.27M | - | 41 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.36
|
$133.50M | - | 41 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.61
|
$117.07M | - | 33 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$29.54
|
$110.20M | - | 35 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.11
|
$84.52M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.84
|
$67.94M | - | 48 | Compare |
|
TENX
Tenax Therapeutics, Inc.
|
$1.62
|
$34.77M | - | 37 | Compare |
|
ZCMD
Zhongchao Inc. Class A Ordinary Shares
|
$0.90
|
$28.94M | - | 54 | Compare |
|
KZIA
Kazia Therapeutics Limited American Depositary Shares
|
$6.62
|
$11.44M | - | 36 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$1.66
|
$4.78M | - | 45 | Compare |
More XTLB Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry